Home » Blog » Is Gabapentin a Narcotic? A Deep Dive into Regulation, Use, and Misuse

Jump to Section

Gabapentin, a widely prescribed prescription medication, is commonly used to treat nerve pain, seizure disorders, and conditions like restless leg syndrome and postherpetic neuralgia. But with its increasing use—and in some cases, misuse—the question arises: Is gabapentin a narcotic or a controlled substance? The short answer: no, gabapentin is not a narcotic, but its regulatory status is evolving rapidly across states, and in some areas, it’s being treated almost as if it were.

Let’s unpack what gabapentin is, how it’s used, and why its classification has sparked debate in the context of the U.S. opioid epidemic.

What Is Gabapentin?

Gabapentin is a CNS drug (central nervous system) that mimics the activity of gamma aminobutyric acid (GABA), a neurotransmitter known for calming neural activity. Originally approved by the Food and Drug Administration (FDA) in 1993, gabapentin is marketed under brand names such as Neurontin and Lyrica CR (though Lyrica itself is a separate compound, pregabalin).

Its primary uses include:

Relieving nerve pain associated with shingles (postherpetic neuralgia)
Managing partial seizures
Off-label treatments for chronic pain, restless leg syndrome, and anxiety disorders

Gabapentin is not classified as an opioid, and it does not bind to opioid receptors, distinguishing it pharmacologically from narcotics.

Is Gabapentin a Narcotic?

From a clinical and legal standpoint, gabapentin is not a narcotic. Narcotics, by definition, refer primarily to opioids—substances that relieve pain but also carry a high potential for abuse, dependency, withdrawal, and fatal overdose. Gabapentin lacks the euphoria-inducing effects typical of opioids and is not derived from the opium poppy.

However, the waters become murkier when we consider gabapentin’s potential for misuse, especially in conjunction with opioids. Its ability to enhance the effects of opioids has made it a drug of interest in the broader discussion about substance abuse, drug abuse, and opioid addiction.

Is Gabapentin a Controlled Substance?

Federally, gabapentin remains a non-controlled substance. The Drug Enforcement Administration (DEA) has not classified it as a Schedule V drug or placed it under any federal schedule as of this writing. This means that, at the federal level, it is not considered a controlled substance.

However, several states have taken independent action. Kentucky, Michigan, West Virginia, North Dakota, and several others, including Connecticut, Indiana, Kansas, and Massachusetts, have reclassified or imposed reporting requirements for gabapentin due to rising concerns about its misuse.

In these states, gabapentin may be:

Listed as a Schedule V controlled substance
Subject to prescription drug monitoring programs (PDMPs)
Tracked more rigorously by pharmacy practice boards and healthcare providers

These actions aim to curb gabapentin misuse, especially when it’s used with opioids to increase the high, potentially leading to breathing problems, respiratory depression, or even opioid-related overdose.

Mandala Healing Center accepts the following insurance providers

The Rise in Gabapentin Prescriptions

Over the last decade, gabapentin has emerged as one of the most prescribed medications in the United States. A 2021 study published in JAMA Internal Medicine found that gabapentin prescriptions increased by nearly 64% between 2012 and 2016, rising from 39 million to over 64 million annually.[1] This spike is partially due to prescribers seeking non-opioid alternatives during the height of the opioid epidemic.

Yet this trend has not come without complications.

Gabapentin Use and Abuse Potential

While initially believed to have low abuse potential, newer research suggests otherwise. Studies indicate that gabapentin abuse is particularly prevalent among individuals with a history of substance abuse, especially opioid abuse.

According to a 2018 report by the Substance Abuse and Mental Health Services Administration (SAMHSA), nearly 1 in 5 individuals misusing opioids also reported gabapentin use, often without a prescription.[2]

The effects of taking gabapentin in high doses or with other prescription medications like opioids can amplify CNS depression, leading to:

Serious side effects
Increased risk of overdose
Withdrawal symptoms
In some cases, immediate medical attention is required

Although the federal government has not yet moved to control gabapentin at a national level, growing pressure from state boards, regulatory affairs experts, and healthcare policy advocates could eventually lead to a shift in its classification.

Why Is Gabapentin Being Reclassified in Some States?

The decision to reclassify gabapentin or include it in prescription drug monitoring programs stems from its emerging role in polysubstance abuse. Several case reports and epidemiological studies have flagged gabapentin use alongside opioids in fatal overdoses, raising red flags for disease control authorities.

As states battle the next phase of the opioid crisis, gabapentin has landed in the spotlight—not as a villain, but as a potential accomplice when misused.

Key concerns driving state action include:

Enhancement of opioid effects leading to respiratory depression
Risk in patients with chronic obstructive pulmonary disease (COPD) or kidney disease
Reports of suicidal thoughts, sedation, and mental health decline
The drug’s availability and perception as a “safe” alternative

How Healthcare Providers Are Responding to Gabapentin Abuse

Given the shifting landscape, prescribing gabapentin now comes with added responsibilities. In states where gabapentin is a federally or locally regulated substance, healthcare providers are required to:

Check PDMP databases before prescribing or refilling
Discuss risk management strategies with patients
Monitor for signs of gabapentin misuse or dependency
Limit gabapentin refills and dosages, especially for patients taking other CNS drugs

The American Journal of Managed Care (Manag Care Pharm) notes that gabapentin regulation is part of a broader initiative to improve pharmacy practice standards and reduce prescription drug abuse across the board.

Risk Factors and Safe Use Guidelines

While gabapentin remains an effective and often necessary drug for neuropathic pain, seizure control, and other health conditions, patients and providers must stay informed.

Risk factors for misuse or complications include:

History of substance use disorders
Co-prescription with opioids or other medications that suppress the CNS
Existing breathing issues or kidney disease
Drinking alcohol while on gabapentin

Patients should never adjust their dosage or discontinue gabapentin use without consulting a healthcare provider.

The Future: Will Gabapentin Become Federally Controlled?

There is growing discussion about whether to classify gabapentin as a federally controlled substance, possibly under Schedule V, the lowest risk category. This would align gabapentin with other Schedule V medications like cough preparations containing less than 200 mg of codeine per 100 mL.

While this change could improve monitoring and substance abuse prevention, critics argue that overregulation may restrict access for patients with legitimate needs.

The federal level decision is pending, but with mounting evidence and state-level actions already in motion, federal reclassification is a strong possibility in the near future.

Get Connected to Treatment for Gabapentin Abuse

So, is gabapentin a narcotic? No—but in today’s complex landscape of prescription drug monitoring, opioid epidemic response, and healthcare policy, the lines are blurring. Whether you’re a provider, patient, or policymaker, understanding gabapentin’s risks, uses, and evolving regulations is essential to navigating its role responsibly.

If you are addicted to gabapentin, it’s time to seek professional help. Contact the Mandala Healing Center today for more information on how we can help you recover.

Frequently Asked Questions (FAQ)

1. Can gabapentin cause withdrawal symptoms if stopped suddenly?

Yes, especially after long-term or high-dose use. While not an opioid, gabapentin can cause physical dependence. Abrupt discontinuation may lead to anxiety, insomnia, nausea, sweating, and in rare cases, seizures. It’s important to taper off under medical supervision.

2. Is it safe to take gabapentin with antidepressants or anti-anxiety medications?

Gabapentin can be taken with certain antidepressants (like SSRIs or SNRIs) or anti-anxiety medications, but combining CNS depressants increases the risk of drowsiness, dizziness, and impaired coordination. Always consult your healthcare provider before combining gabapentin with other prescription medications.

3. How long does it take for gabapentin to start working for nerve pain?

For most people, gabapentin begins to relieve nerve pain within one to two weeks, though full effects may take longer depending on dosage adjustments and individual response. If no improvement is seen after a few weeks, your provider may reassess your treatment plan.

4. Can gabapentin be used long-term for chronic conditions?

Yes, but with monitoring. While gabapentin is commonly used for chronic conditions like neuropathic pain, long-term use should include regular evaluations for effectiveness, side effects, and signs of misuse or dependency. Dosage may also need to be adjusted over time.

5. Are there dietary or lifestyle restrictions when taking gabapentin?

Alcohol should be avoided due to the risk of increased sedation and respiratory depression. There are no major food restrictions, but taking gabapentin with food can help reduce stomach upset. Patients with kidney issues should be cautious and may need dosage adjustments.

6. Why is gabapentin prescribed off-label for so many conditions?

Gabapentin affects the nervous system in ways that can benefit multiple conditions beyond its FDA-approved uses. This includes off-label treatment for anxiety, chronic pain syndromes, and migraines. Its relatively low addiction potential—compared to opioids—has made it a go-to for pain management alternatives, though that perception is evolving with newer data.

References:

United States Drug Testing Laboratories: Gabapentin, An Emerging Threat in Today’s Opioid Epidemic
JAMA Network: Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices